Progenitor cell mobilisation and recruitment in pulmonary arteries in chronic obstructive pulmonary disease.


Journal

Respiratory research
ISSN: 1465-993X
Titre abrégé: Respir Res
Pays: England
ID NLM: 101090633

Informations de publication

Date de publication:
16 Apr 2019
Historique:
received: 05 11 2018
accepted: 12 03 2019
entrez: 18 4 2019
pubmed: 18 4 2019
medline: 23 8 2019
Statut: epublish

Résumé

Pulmonary vascular abnormalities are a characteristic feature of chronic obstructive pulmonary disease (COPD). Cigarette smoking is the most important risk factor for COPD. It is believed that its constant exposure triggers endothelial cell damage and vascular remodelling. Under pathological conditions, progenitor cells (PCs) are mobilized from the bone marrow and recruited to sites of vascular injury. The aim of the study was to investigate whether in COPD the number of circulating PCs is related to the presence of bone marrow-derived cells in pulmonary arteries and the association of these phenomena to both systemic and pulmonary endothelial dysfunction. Thirty-nine subjects, 25 with COPD, undergoing pulmonary resection because of a localized carcinoma, were included. The number of circulating PCs was assessed by flow cytometry using a triple combination of antibodies against CD45, CD133 and CD34. Infiltrating CD45 COPD patients had reduced numbers of circulating PCs (p < 0.05) and increased numbers of CD45 In COPD, the decrease of circulating PCs is associated with their recruitment in pulmonary arteries, which in turn is associated with endothelial dysfunction and vessel remodelling, suggesting a mechanistic link between these phenomena. Our findings are consistent with the notion of an imbalance between endothelial damage and repair capacity in the pathogenesis of pulmonary vascular abnormalities in COPD.

Sections du résumé

BACKGROUND BACKGROUND
Pulmonary vascular abnormalities are a characteristic feature of chronic obstructive pulmonary disease (COPD). Cigarette smoking is the most important risk factor for COPD. It is believed that its constant exposure triggers endothelial cell damage and vascular remodelling. Under pathological conditions, progenitor cells (PCs) are mobilized from the bone marrow and recruited to sites of vascular injury. The aim of the study was to investigate whether in COPD the number of circulating PCs is related to the presence of bone marrow-derived cells in pulmonary arteries and the association of these phenomena to both systemic and pulmonary endothelial dysfunction.
METHODS METHODS
Thirty-nine subjects, 25 with COPD, undergoing pulmonary resection because of a localized carcinoma, were included. The number of circulating PCs was assessed by flow cytometry using a triple combination of antibodies against CD45, CD133 and CD34. Infiltrating CD45
RESULTS RESULTS
COPD patients had reduced numbers of circulating PCs (p < 0.05) and increased numbers of CD45
CONCLUSION CONCLUSIONS
In COPD, the decrease of circulating PCs is associated with their recruitment in pulmonary arteries, which in turn is associated with endothelial dysfunction and vessel remodelling, suggesting a mechanistic link between these phenomena. Our findings are consistent with the notion of an imbalance between endothelial damage and repair capacity in the pathogenesis of pulmonary vascular abnormalities in COPD.

Identifiants

pubmed: 30992021
doi: 10.1186/s12931-019-1024-z
pii: 10.1186/s12931-019-1024-z
pmc: PMC6469212
doi:

Types de publication

Journal Article

Langues

eng

Pagination

74

Subventions

Organisme : Instituto de Salud Carlos III
ID : PI05/0244
Organisme : Instituto de Salud Carlos III
ID : PI12/00510
Organisme : Instituto de Salud Carlos III
ID : PI16/01147
Organisme : Instituto de Salud Carlos III
ID : PIE15/00582
Organisme : Instituto de Salud Carlos III
ID : predoctoral research fellowship (PFIS)
Organisme : Instituto de Salud Carlos III
ID : CP17/00114
Organisme : Fundació la Marató de TV3
ID : 04310
Organisme : Sociedad Española de Neumología y Cirugía Torácica
ID : 24/2015
Organisme : Hospital Clinic Barcelona
ID : predoctoral research fellowship
Organisme : H2020 Marie Skłodowska-Curie Actions
ID : Marie Curie Post-Doctoral Fellowship Award BIOTRACK: IDIBAPS

Références

J Am Coll Cardiol. 2002 Jan 16;39(2):257-65
pubmed: 11788217
Arterioscler Thromb Vasc Biol. 2004 Aug;24(8):1442-7
pubmed: 15191940
Circulation. 2005 Jun 7;111(22):2981-7
pubmed: 15927972
Am J Respir Cell Mol Biol. 2006 Mar;34(3):257-63
pubmed: 16239642
Development. 2006 Apr;133(8):1543-51
pubmed: 16524930
Dev Biol. 1991 Feb;143(2):235-47
pubmed: 1703972
PLoS Med. 2006 Nov;3(11):e442
pubmed: 17132052
Cardiovasc Res. 2007 Dec 1;76(3):517-27
pubmed: 17850777
J Am Coll Cardiol. 2008 May 6;51(18):1760-71
pubmed: 18452782
Circulation. 2008 Jun 10;117(23):3020-30
pubmed: 18519847
Chest. 2008 Oct;134(4):808-14
pubmed: 18842913
Am J Respir Crit Care Med. 2009 Sep 15;180(6):513-20
pubmed: 19542477
EMBO J. 2012 Feb 15;31(4):842-55
pubmed: 22179698
Lancet. 2012 Apr 7;379(9823):1341-51
pubmed: 22314182
Regen Med. 2012 Nov;7(6):833-50
pubmed: 23164083
Lancet. 2012 Dec 15;380(9859):2095-128
pubmed: 23245604
World J Cardiol. 2012 Dec 26;4(12):312-26
pubmed: 23272272
Am J Physiol Lung Cell Mol Physiol. 2013 Dec;305(12):L964-9
pubmed: 24142520
COPD. 2014 Jun;11(3):277-89
pubmed: 24182349
PLoS One. 2014 Aug 29;9(8):e106163
pubmed: 25171153
Eur Respir J. 2015 Nov;46(5):1247-50
pubmed: 26521275
Can Respir J. 2016;2016:1472823
pubmed: 27445517
Respir Res. 2017 Mar 23;18(1):50
pubmed: 28330488
J Thorac Dis. 2017 Jul;9(7):2168-2177
pubmed: 28840018
Mol Med Rep. 2017 Oct;16(4):5294-5302
pubmed: 28849108
PLoS One. 2018 Apr 19;13(4):e0195724
pubmed: 29672621
Am J Respir Crit Care Med. 1994 Feb;149(2 Pt 1):423-9
pubmed: 8306040
Am J Physiol. 1998 Jun;274(6):L908-13
pubmed: 9609729

Auteurs

Olga Tura-Ceide (O)

Department of Pulmonary Medicine, Hospital Clínic-Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), University of Barcelona, Barcelona, Spain. info@idibaps.org.
Biomedical Research Networking Center on Respiratory Diseases (CIBERES), Madrid, Spain. info@idibaps.org.
Servei de Pneumologia, Hospital Clínic, Villarroel, 170, 08036, Barcelona, Spain. info@idibaps.org.

Sandra Pizarro (S)

Department of Pulmonary Medicine, Hospital Clínic-Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), University of Barcelona, Barcelona, Spain.

Jéssica García-Lucio (J)

Department of Pulmonary Medicine, Hospital Clínic-Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), University of Barcelona, Barcelona, Spain.

Josep Ramírez (J)

Department of Pathology, Hospital Clínic-Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), University of Barcelona, Barcelona, Spain.

Laureano Molins (L)

Department of Thoracic Surgery, Hospital Clínic-Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), University of Barcelona, Barcelona, Spain.
Biomedical Research Networking Center on Respiratory Diseases (CIBERES), Madrid, Spain.

Isabel Blanco (I)

Department of Pulmonary Medicine, Hospital Clínic-Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), University of Barcelona, Barcelona, Spain.
Biomedical Research Networking Center on Respiratory Diseases (CIBERES), Madrid, Spain.

Yolanda Torralba (Y)

Department of Pulmonary Medicine, Hospital Clínic-Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), University of Barcelona, Barcelona, Spain.
Biomedical Research Networking Center on Respiratory Diseases (CIBERES), Madrid, Spain.

Marta Sitges (M)

Department of Cardiology, Hospital Clínic-Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), University of Barcelona, Barcelona, Spain.
Biomedical Research Networking Center on Cardiovascular Diseases (CIBERCV), Madrid, Spain.

Cristina Bonjoch (C)

Department of Pulmonary Medicine, Hospital Clínic-Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), University of Barcelona, Barcelona, Spain.

Victor I Peinado (VI)

Department of Pulmonary Medicine, Hospital Clínic-Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), University of Barcelona, Barcelona, Spain.
Biomedical Research Networking Center on Respiratory Diseases (CIBERES), Madrid, Spain.

Joan Albert Barberà (JA)

Department of Pulmonary Medicine, Hospital Clínic-Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), University of Barcelona, Barcelona, Spain. info@idibaps.org.
Biomedical Research Networking Center on Respiratory Diseases (CIBERES), Madrid, Spain. info@idibaps.org.
Servei de Pneumologia, Hospital Clínic, Villarroel, 170, 08036, Barcelona, Spain. info@idibaps.org.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH